Herbert Chen, | |
1717 6th Ave S, Birmingham, AL 35233-1801 | |
(800) 822-8816 | |
Not Available |
Full Name | Herbert Chen |
---|---|
Gender | Male |
Speciality | Surgical Oncology |
Experience | 32 Years |
Location | 1717 6th Ave S, Birmingham, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366407033 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 34498 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Alabama Hospital | Birmingham, AL | Hospital |
Callahan Eye Hospital | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
As Medicare crime spreads across South Florida, accused scammers are escaping in droves to Cuba and other Latin American countries to avoid prosecution — with more than 150 fugitives now wanted for stealing hundreds of millions of dollars from the U.S. health care program, according to the FBI and court records.
A UK study in this week's issue of THE LANCET provides further evidence that gene therapy can be effective in creating a functional immune system for infants with severe combined immunodeficiency (SCID).
Presidio Pharmaceuticals, Inc. announced today that they have selected a second clinical candidate, PPI-1301, from their hepatitis C virus (HCV) NS5A program for advancement into clinical development. Presidio's first NS5A inhibitor, PPI-461, is currently undergoing evaluation in a Phase 1a clinical study.
A new study by Yale School of Medicine researchers provides insight into how much women of reproductive age in the United States know about reproductive health.
› Verified 2 days ago
Entity Name | University Of Alabama Health Services Foundation, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
As Medicare crime spreads across South Florida, accused scammers are escaping in droves to Cuba and other Latin American countries to avoid prosecution — with more than 150 fugitives now wanted for stealing hundreds of millions of dollars from the U.S. health care program, according to the FBI and court records.
A UK study in this week's issue of THE LANCET provides further evidence that gene therapy can be effective in creating a functional immune system for infants with severe combined immunodeficiency (SCID).
Presidio Pharmaceuticals, Inc. announced today that they have selected a second clinical candidate, PPI-1301, from their hepatitis C virus (HCV) NS5A program for advancement into clinical development. Presidio's first NS5A inhibitor, PPI-461, is currently undergoing evaluation in a Phase 1a clinical study.
A new study by Yale School of Medicine researchers provides insight into how much women of reproductive age in the United States know about reproductive health.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Herbert Chen, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Herbert Chen, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
As Medicare crime spreads across South Florida, accused scammers are escaping in droves to Cuba and other Latin American countries to avoid prosecution — with more than 150 fugitives now wanted for stealing hundreds of millions of dollars from the U.S. health care program, according to the FBI and court records.
A UK study in this week's issue of THE LANCET provides further evidence that gene therapy can be effective in creating a functional immune system for infants with severe combined immunodeficiency (SCID).
Presidio Pharmaceuticals, Inc. announced today that they have selected a second clinical candidate, PPI-1301, from their hepatitis C virus (HCV) NS5A program for advancement into clinical development. Presidio's first NS5A inhibitor, PPI-461, is currently undergoing evaluation in a Phase 1a clinical study.
A new study by Yale School of Medicine researchers provides insight into how much women of reproductive age in the United States know about reproductive health.
› Verified 2 days ago
Melanie Morris, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Rebecca Horst, PA Surgery Medicare: Medicare Enrolled Practice Location: 817 Princeton Ave Sw Ste 306, Birmingham, AL 35211 Phone: 205-783-0160 Fax: 205-788-6249 | |
Timothy Lee Christopher, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 400, Birmingham, AL 35243 Phone: 205-595-8985 Fax: 205-595-8987 | |
Dr. Richard Ira Kirkland, MD Surgery Medicare: Medicare Enrolled Practice Location: 513 Brookwood Blvd, Suite 501, Birmingham, AL 35209 Phone: 205-930-8010 Fax: 205-930-8014 | |
Kyle Stigall, MD Surgery Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-4011 | |
Jayme Locke, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Emily Long, MD Surgery Medicare: Medicare Enrolled Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3000 |